Acrivon Therapeutics, Inc. financial data

Symbol
ACRV on Nasdaq
Location
Watertown, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1018% % -20%
Debt-to-equity 11% % 16%
Return On Equity -54% % -12%
Return On Assets -48% % -10%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31,555,126 shares 1.3%
Common Stock, Shares, Outstanding 31,549,770 shares 1.3%
Entity Public Float $99,100,000 USD -37%
Common Stock, Value, Issued $31,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 38,560,464 shares 1.2%
Weighted Average Number of Shares Outstanding, Diluted 38,560,464 shares 1.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $63,874,000 USD 5%
General and Administrative Expense $25,078,000 USD 2.5%
Operating Income (Loss) $88,952,000 USD -4.3%
Nonoperating Income (Expense) $7,201,000 USD -13%
Net Income (Loss) Attributable to Parent $81,751,000 USD -6.2%
Earnings Per Share, Basic -2 USD/shares 24%
Earnings Per Share, Diluted -2 USD/shares 24%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $35,405,000 USD -18%
Assets, Current $130,361,000 USD -31%
Property, Plant and Equipment, Net $5,189,000 USD 11%
Operating Lease, Right-of-Use Asset $2,792,000 USD -26%
Other Assets, Noncurrent $1,647,000 USD 40%
Assets $145,299,000 USD -32%
Accounts Payable, Current $996,000 USD -34%
Liabilities, Current $14,891,000 USD 0.49%
Operating Lease, Liability, Noncurrent $1,805,000 USD -39%
Liabilities $16,696,000 USD -6.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $112,000 USD -86%
Retained Earnings (Accumulated Deficit) $255,896,000 USD -47%
Stockholders' Equity Attributable to Parent $128,603,000 USD -35%
Liabilities and Equity $145,299,000 USD -32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $19,535,000 USD -14%
Net Cash Provided by (Used in) Financing Activities $343,000 USD -99%
Net Cash Provided by (Used in) Investing Activities $19,214,000 USD 228%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 31,549,770 shares 1.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $664,000 USD 94%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $35,607,000 USD -18%
Deferred Tax Assets, Valuation Allowance $56,650,000 USD 78%
Deferred Tax Assets, Gross $57,922,000 USD 74%
Operating Lease, Liability $2,989,000 USD -26%
Depreciation $1,193,000 USD 28%
Payments to Acquire Property, Plant, and Equipment $58,000 USD -93%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $82,421,000 USD -8.6%
Lessee, Operating Lease, Liability, to be Paid $3,293,000 USD -28%
Property, Plant and Equipment, Gross $8,146,000 USD 29%
Operating Lease, Liability, Current $1,184,000 USD 14%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,210,000 USD -8.7%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,338,000 USD 0.08%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $304,000 USD -49%
Lessee, Operating Lease, Liability, to be Paid, Year Three $404,000 USD -67%
Deferred Tax Assets, Operating Loss Carryforwards $15,668,000 USD 67%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $404,000 USD -66%
Operating Lease, Payments $200,000 USD -33%
Additional Paid in Capital $384,356,000 USD 3.8%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $1,272,000 USD -17%
Share-based Payment Arrangement, Expense $15,336,000 USD 12%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%